Dr. Reddy’s Laboratories launches Olanzapine tablets

25 Apr 2012 Evaluate

Dr. Reddy’s Laboratories has launched Olanzapine tablets (2.5mg, 5mg, 7.5mg, 10mg, 15mg), a bioequivalent generic version of ZYPREXA tablets in the US market on April 23, 2012 following the approval by the United States Food & Drug Administration (USFDA) of the company's ANDA for Olanzapine tablets.

Dr. Reddy’s Olanzapine tablets in 20 mg had been awarded a 180-day period of marketing exclusivity in the US on October 26, 2011 which was commercialized through a commercial, manufacture and supply agreement with Teva Pharmaceutical Industries.

The ZYPREXA tablets brand and generic had combined US sales of approximately $3.28 billion for the most recent twelve months ending January 2012 according to IMS Health.

Dr. Reddy’s Olanzapine tablets in 2.5mg, 5mg, 7.5mg, 10mg, 15mg and 20mg strengths are available in 30 and 500 count bottles.

Dr. Reddys Lab Share Price

1267.50 1.55 (0.12%)
31-Dec-2025 12:03 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1720.00
Dr. Reddys Lab 1267.50
Cipla 1500.80
Zydus Lifesciences 912.35
Lupin 2102.60
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×